We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PST:MILPoste Italiane SpA Analysis

Data as of 2026-06-18 - not real-time

€29.23

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Poste Italiane is trading firmly above its short‑term and medium‑term moving averages, confirming a bullish price direction. The relative strength index is perched in the overbought territory, signalling that upward momentum may be nearing a climax. A bullish MACD crossover and rising volume reinforce the technical strength, while the current price sits just below a well‑tested resistance level. The stock also boasts an attractive dividend yield that outperforms many peers, and the payout ratio remains comfortably below the threshold that would threaten cash sustainability.
Fundamentally, the company posted solid revenue growth and healthy operating margins, supported by strong cash generation and a robust free cash flow profile. Return on equity is respectable, and the balance sheet shows ample cash despite a sizable debt load that reflects its public‑service nature. Compared with industry peers, the valuation multiples appear markedly lower, suggesting a discount relative to the broader market. However, regulatory oversight and the high leverage introduce a degree of caution for the long haul.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • price approaching key resistance
  • RSI in overbought zone
  • increasing volume supports bullish bias but warrants caution

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • valuation multiple well below industry average
  • strong dividend yield with sustainable payout
  • steady cash flow and earnings growth

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • elevated debt level relative to equity
  • potential regulatory changes affecting postal and financial services
  • consistent dividend policy providing income stability

Key Metrics & Analysis

Financial Health

Revenue Growth8.50%
Profit Margin16.99%
P/E Ratio15.5
ROE19.02%
ROA0.75%
Debt/Equity723.59
P/B Ratio3.0
Op. Cash Flow€3.0B
Free Cash Flow€3.5B
Industry P/E31.2

Technical Analysis

TrendBullish
RSI88.8
Support€24.67
Resistance€29.31
MA 20€26.35
MA 50€24.26
MA 200€21.93
MACDBullish
VolumeIncreasing
Fear & Greed Index88.5

Valuation

Target Price€25.19
Upside/Downside-13.81%
GradeUndervalued
TypeBlend
Dividend Yield4.31%

Risk Assessment

Beta0.43
Volatility17.21%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.